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A B S T R A C T
The aim of the study was to investigate prescription of anxiolytics and antidepressants among Slovenian family phy-
sicians regarding drug class with an emphasis on the elderly population and possible time-trends. Exploratory survey
and register-based analysis of anxiolytic and antidepressant prescriptions of one hundred family physicians in Slovenia
was performed in 2005 and 2008. Drugs included in the study were classified according to the Anatomical-Therapeu-
tic-Chemical (ATC) drug classification system, and ATC data were used to calculate defined daily doses (DDD) per 1,000
practice population per day. The most often prescribed anxiolytics and antidepressants were identified and anxiolyt-
ic/antidepressant ratio was estimation by patient age-group for the two studied years. Benzodiazepines showed highest
share in the overall utilization of psychotropic drugs. The ratio between short- and long-acting benzodiazepines de-
creased by about one tenth during the observed period. Long-acting benzodiazepines were prescribed more often to the
older patients. The decrease in anxiolytic/antidepressant ratio from 2005 to 2008 was the smallest in the elderly popula-
tion. Further research is needed to ascertain the prescribers’ attitudes in order to devise strategies to further improve pre-
scribing performance in elderly patients.
Key words: family physicians, drug prescriptions, anxiolytics, antidepressants, ATC/DDD methodology, elderly, Slovenia
Introduction
In Slovenia, about one third of patients in general
practice suffer from mental disorder and receive psycho-
tropic drug prescription1. A large majority of mental
health consultations is for elderly patients2. The most
prevalent mental disorders in this group of patients are
depression and anxiety. The estimated prevalence of de-
pression in the elderly visiting family physicians is 15%.
This proportion is even larger in the elderly with somatic
diseases3. The elderly population with somatic and men-
tal health needs is cared for in the primary care settings
with the possibility of referral to the secondary level. Due
to severe shortage of psychiatrists working in geron-
topsychiatry in Slovenia, these referrals are very rare. If
they nevertheless happen, the patients are subsequently
re-allocated to primary care for further follow-up4.
Family physicians, being the exclusive primary treat-
ment providers in Slovenia, are allowed to prescribe al-
most every psychotropic drug. They often prescribe anti-
depressants and anxiolytics; among the latter, they mainly
prescribe benzodiazepines5. Therapeutic indications for
benzodiazepines include treatment of insomnia, general-
ized anxiety disorder, panic disorder, and social phobia.
They are used for acute agitation and as supplementary
treatment for mania. Further uses include skeletal mus-
cle relaxation and adjunctive treatment for seizure disor-
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ders. Generally, benzodiazepines are indicated for acute
symptom relief and have considerable potential efficacy
when used in this manner6. Problems associated with
benzodiazepine use include daytime sedation and consec-
utively increased risk for motor vehicle accidents, falls
and hip fractures7. Longer-term benzodiazepine use in-
duces physical and psychological addiction, withdrawal
symptoms when discontinuing the treatment and cogni-
tive impairment8. It is generally recognized that long-
-acting benzodiazepines are less safe than short-acting
agents, since they increase risk of daytime psychomotor
impairment and sedation9. The drug use patterns with
regard to patients’ age and gender in Slovenia are consis-
tent with findings from other countries5,10–12. Benzodiaz-
epines are more often prescribed to the older, female and
less educated patients, and the user rates for both gen-
ders increase with patients’ age. This population is prone
to fractures due to osteoporosis, often suffer severe and
multifaceted problems, receive multiple drugs, and is less
avare of the potential side-effects of the drugs5.
Moreover, benzodiazepines can erroneously be used to
treat symptoms of depression rather than depression it-
self, because anxiety commonly coexists with depression
in older people13. There is growing awareness about the
therapeutic effect of the new generation of antidepres-
sants for these complex disorders14. In spite of lack of ad-
diction problem, new generation of antidepressants (e.g.
selective serotonin reuptake inhibitors, SSRIs, and sero-
tonin-norepinephrine reuptake inhibitors, SNRIs) show
other drug-related problems, such as sexual dysfunction,
risk of bleeding, hyponatremia, discontinuation symp-
toms, increased body weight and increased risk of diabe-
tes mellitus15. Guidelines defining the appropriate use of
benzodiazepines in the elderly recommend that prescrip-
tions be intermittent, brief, and limited to the acute
treatments during the first several weeks. It has been a
clinical routine to treat depression first and then taper
off the benzodiazepine while antidepressive treatment is
continued16. Despite the concerns, benzodiazepine use in
older adults remains high, with a prevalence of 10% to
12% in older adults residing in the community17, and
likely reflects unnecessary or suboptimal treatment18.
The anxiolytic/antidepressant ratio is one of the indi-
cators of quality of prescribing, whereby antidepressants
as etiological therapy should prevail19. In 2003, the ratio
of anxiolytics/antidepressants was 2.1 for Slovenia19, 0.3
for Sweden, 0.5 for Norway, 0.7 for Denmark and 4.66 for
Croatia20. Appropriate anxiolytic/antidepressant ratio is
yet to be defined. There may be a threshold for reduction
of benzodiazepine utilization beyond which a further de-
crease may be difficult unless additional alternative treat-
ments are successfully implemented21.
Even though Slovenia is a country with one of the
highest suicide rates in elderly population22, no study has
been conducted regarding prescribing of benzodiazepines
in the elderly patient population. Recent research only
estimated annual benzodiazepine consumption in a gen-
eral population23. Therefore, the objectives of this study
were to estimate the prescription of different types of
anxiolytics and antidepressants among Slovenian family
physicians, to compare the utilization of anxiolytics and
antidepressants according to age of the patient popula-
tion using the World Health Organization Anatomical-
-Therapeutic-Chemical classification system (ATC)/De-
fined Daily Doses (DDD) methodology, to examine chan-
ges between 2005 and 2008, and to propose appropriate
interventions on the basis of the obtained results.
Materials and Methods
Physician sampling and surveying
Data were obtained from the national database of all
prescriptions, which is maintained by the Slovenian In-
stitute of Public Health (SIPH). A representative sample
of 160 family physicians was selected by means of strati-
fied random sampling. The sample was well-matched to
the total population in terms of regional representation,
age distribution, gender ratio and percentage of public
and private practitioners. The study did not include phy-
sicians who worked part time, who were absent from
work for over 3 months during the studied year, and/or
those who were retired or worked at emergency depart-
ments. In order to ensure the physicians’ collaboration, a
letter explaining the aims and procedures of the survey
was attached. A coding system was used to facilitate fol-
low-up with two reminders in order to increase response
rate while keeping the family physician’s identity confi-
dential. The positive response was obtained by 100 fam-
ily physicians, yielding a 62.5% response rate. Further
analyses were performed on the respondent sample be-
cause the non-respondents did not consent to the use of
their data from the SIPH prescription database.
Prescribing data
From the national database, data on the prescribed
medications were obtained for the year 2005 and 2008. In
total, 121,638 prescriptions for anxiolytic and antide-
pressant drugs were analysed: 52,935 from 2005 and
68,703 from 2008. Data on the size and number of pack-
ages were obtained for each individual drug. Drugs were
coded according to the ATC classification system.
Data analysis
The number of DDD, and DDD per 1000 practice pop-
ulation per day (DDD/1000/day) were calculated for an-
xiolytics and antidepressants using ATC indexes for 2005
and 2008. The required population data were obtained as
publicly available from the Statistical Office of the Re-
public of Slovenia (http://www.stat.si). The anxiolytics/
antidepressants ratio was calculated as the ratio of the
estimated standardised prescribing amount in DDD per
1000 practice population per day between anxiolytics and
antidepressants, and used as a criterion of prescribing
quality19. Descriptive comparisons of the calculated quan-
tities regarding age and gender of the patient population
were performed within and between the two studied
years.
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Results
Prescription data for the whole patient population for
individual drugs are presented in Table 1. In both ob-
served years, short-acting alprazolam was the most often
prescribed benzodiazepine (6.5 and 5.8 DDD per 1000
practice population per day in 2005 and 2008, respec-
tively), followed by bromazepam (intermediate-acting;
4.4 and 3.7 DDD/1000/day), diazepam (long-acting; 4.3
and 3.4 DDD/1000/day) and lorazepam (intermediate-
-acting; 3.4 and 3.2 DDD/1000/day in 2005 and 2008, re-
spectively), while the other three anxiolytics were pre-
scribed rarely. Among antidepressants, SSRIs were clearly
dominant, with sertralin being the most often prescribed
in both studied years (5.8 and 8.2 DDD/1000/day in 2005
and 2008, respectively).
The ratio between short- and long-acting benzodiaze-
pines in 2005 and 2008 is presented in Table 2. For the
purpose of this comparison, intermediate-acting benzo-
diazepines were included in the short-acting group. Short-
-acting BZD were used more often (13.2 and 15.0 DDD/
1000/day in 2005 and 2008, respectively). The ratio de-
creased from 2005 to 2008 by about one tenth.
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TABLE 1
ESTIMATED STANDARDISED PRESCRIBING AMOUNT OF INDIVIDUAL DRUGS (SORTED BY DECREASING AMOUNT WITHIN DRUG
CLASS) FOR THE WHOLE PATIENT POPULATION
Drug class Drug ATC
2005 2008
DDD/1000/day Rank DDD/1000/day Rank
Anxiolytics
Alprazolam (short-acting) N05BA12 6.51 1 5.82 1
Bromazepam (intermediate-acting) N05BA08 4.41 2 3.73 2
Diazepam (long-acting) N05BA01 4.28 3 3.39 3
Lorazepam (intermediate-acting) N05BA06 3.40 4 3.18 4
Oxazepam (intermediate-acting) N05BA04 0.66 5 0.49 5
Medazepam (long-acting) N05BA03 0.32 6 0.25 6
Clobazam (long-acting) N05BA09 0.13 7 0.16 7
Antidepres-
sants
Sertraline (SSRI) N06AB06 5.84 1 8.23 2
Escitalopram (SSRI) N06AB10 4.45 2 8.40 1
Citalopram (SSRI) N06AB04 2.99 3 2.76 4
Paroxetine (SSRI) N06AB05 2.69 4 4.47 3
Fluoxetine (SSRI) N06AB03 1.58 5 1.24 5
Tianeptine (SSRE) N06AX14 0.68 6 0.99 7
Venlafaxine (SNRI) N06AX16 0.63 7 1.14 6
Amitriptyline (TCA) N06AA09 0.61 8 0.59 10
Moclobemide (MAOI) N06AG02 0.43 9 0.24 11
Maprotiline (TeCa) N06AA21 0.33 10 0.22 12
Mirtazapine (TeCA) N06AX11 0.24 11 0.73 9
Mianserin (TeCA) N06AX03 0.08 12 0.08 13
Clomipramine (TCA) N06AA04 0.05 13 0.05 14
Reboxetine (NRI) N06AX18 0.04 14 0.02 16
Doxepin (TCA) N06AA12 0.04 15 0.02 15
Fluvoxamine (SSRI) N06AB08 0.02 16 18
Duloxetine (SNRI) N06AX21 0.01 17 0.79 8
Herbion Hypericum N06AW01 18 0.00 17
DDD/1000/day – defined daily dose per 1,000 practice population per day; SSRI – selective serotonin reuptake inhibitors; SSRE – selec-
tive serotonin reuptake enhancers; SNRI – serotonin norepinephrine reuptake inhibitor; NRI – norepinephrine reuptake inhibitor;
TCA – tricyclic antidepressants; TeCA – tetracyclic antidepressants
TABLE 2
ESTIMATED STANDARDISED PRESCRIBING AMOUNT OF
SHORT- AND LONG-ACTING BENZODIAZEPINES FOR THE
WHOLE PATIENT POPULATION
DDD/1000/day
Benzodiazepine type 2005 2008
Short-acting 13.22 14.98
Long-acting 3.80 4.74
Ratio (short- vs. long-acting) 3.48 3.16
Ratio relative to 2005 100% 90.8%
DDD/1000/day – defined daily dose per 1,000 practice population
per day
The distribution of short- and long-acting benzodiaze-
pines among age groups is presented in Figure 1 (like in
Table 2, intermediate-acting benzodiazepines are inclu-
ded in the short-acting group). Long-acting benzodiaze-
pines were prescribed more often to patients aged 50
years or more than to the younger ones, with particularly
pronounced prescribing in the 70–79 years category (1.1
and 0.9 DDD/1000/day in 2005 and 2008, respectively).
The use of different antidepressant drugs in different
age groups is presented in Figure 2. SSRIs were pre-
scribed to the large majority of the patients (note the
base-2 logarithmic horizontal axis used as a consequen-
ce). There was little difference between the age groups,
i.e., the distribution of each antidepressant type across
age groups was similar to the combined distribution
across age groups.
Figure 3 shows the anxiolytic/antidepressant ratio in
different age groups. In general, the ratio increases with
age, which is probably attributable to comorbidity and
case-mix of diagnoses that leads to higher use of benzo-
diazepines with growing patient age. It decreased over
the observed time-period in all age groups (by about one
third, more precisely ranging from 28% to 45%) except in
the youngest (aged 18–20) and the oldest patients (aged
90+), where it increased (by 40% and 6%, respectively).
However, due to the very small numbers of patients in
the two extreme age groups, this finding is less reliable
and hence less worrying.
Discussion
This study was conducted to obtain better knowledge
about prescribing patterns of anxiolytics and antidepres-
sants in Slovenia, especially in the elderly patient popu-
lation. It has previously been established that the amo-
unt of prescribed anxiolytics in Slovenia, whether esti-
mated in absolute terms or as DDD per 1000 practice
population per day, decreased by about 14%, and the
amount of prescribed antidepressants increased by about
45% during the observed 4-year period, leading to the
anxiolytic/antidepressant ratio reduction from almost 1
to about 0.524. This reduction of anxiolytic/antidepres-

















































































Fig. 1. Estimated distribution of standardised prescribing (in
DDD/1000/day – defined daily dose per 1,000 practice population
per day) of short- and long-acting benzodiazepines (BZD) across



























































































































































































































Fig. 2. Estimated standardised prescribing (in DDD/1000/day –
defined daily dose per 1,000 practice population per day) of dif-
ferent antidepressant drugs by age group in 2005 in 2008 (SSRI
– selective serotonin reuptake inhibitors; SSRE – selective seroto-
nin reuptake enhancers; SNRI – serotonin norepinephrine reup-
take inhibitor; NRI – norepinephrine reuptake inhibitor; TCA –

















































Fig. 3. Distribution of anxiolytic/antidepressant ratio across age
groups in 2005 in 2008.
sant ratio indicates significant improvement in prescrib-
ing practice of Slovenian family physicians.
However, in both observed years, benzodiazepines
showed highest share in the overall utilisation of psy-
chotropic drugs, with short-acting alprazolam being the
most often prescribed anxiolytic. As new generation hyp-
notics, benzodiazepine related drugs are currently rec-
ommended to use in treatment of insomnia25, so the con-
sumption of these drugs in Slovenia is surprisingly low.
Short-acting benzodiazepines are thus introduced as drugs
of choice for sedation and anxiolysis in Slovene family
practice. A similar trend of decreased prescribing of
long-acting benzodiazepines has been observed in studies
in Canada21, in Holland26, and in Nova Scotia27. In the
group of antidepressants, SSRIs accounted for the high-
est share of utilisation and showed a rising trend in the
observed period.
Increasing age is related to increased incidence of
physical illness, mental deterioration or loss of func-
tional independence. Depression and anxiety disorders
are often difficult to diagnose because of the variety of
clinical presentations and the common occurrence of
comorbid medical or other psychiatric conditions28. Dis-
continuation of anxiolytic treatment is also difficult for
the elderly who were prescribed anxiolytics for long peri-
ods before the anxiolytic effects of new generation of an-
tidepressants was known. Physicians in Slovenia and
other countries have difficulties with refusing the pre-
scription of an anxiolytic, especially if the patient had
positive experiences with these drugs before24,29.
Additional difficulty is posed by the high workload of
Slovenian family physicians, which is higher than in
many of their European collegues30, leaving the physi-
cians little time for counselling, prevention and referral
to psychiatric service, which obviously generates the
need to discriminate among perspective and less-per-
spective (i.e., older) patients. This inevitably leads to re-
ductions in counselling, support and treatment options
in the latter group. Another problem is insufficient com-
munication with psychiatrists and psychologists because
of their low number and extremely uneven distribution.
Namely, almost half of Slovenian psychiatrists work in
the central region and the access to psychiatric facilities
in remote regions, where a large part of the older popula-
tion live, is difficult31. There is also the problem of stigma
of mental disorders, which is even stronger for the old-
-age population. Old people with chronic anxiety and de-
pression and/or addicted to benzodiazepines might not be
seen as candidates for treatment of addiction disorders.
Physicians tend to anticipate patients’ reluctance to chan-
ge medication and overcome withdrawal reactions, and
report about history of failed attempts to abandon the
drug, especially if the patient is old32. Hence, a number of
approaches could be used to implement guidelines and
reverse current trends in relation to anxiolytic prescrib-
ing among the elderly. Options include delivering a clea-
rer message related to outcomes, communicating effec-
tively using opinion leaders and other evidenced tech-
niques, and enabling doctors and also patients to under-
stand the true relative advantages, disadvantages, and con-
sequences of using these drugs in this patient population8.
In all age groups, but particularly in the older age
groups, far more women received anxiolytics than did
men. This difference among recipients of anxiolytics pos-
sibly originates from the time of the initial prescription.
Doctors frequently diagnose women with symptoms such
as headache and general fatigue (not legitimate indica-
tions for anxiolytics) as suffering from anxiety, stress or
insomnia (which are legitimate indications) and thus as
candidates for anxiolytic treatment, thus more women
than men are initially prescribed anxiolytics for condi-
tions other than anxiety, stress or insomnia. However, in-
formation on patient diagnosis or on severity of symp-
toms would be needed to determine whether the present
results reflect gender differences in medical care needs,
overprescription of psychotropic drugs to females or un-
derprescription of psychotropic drugs to males33.
Most Slovenian family physicians are aware of pre-
scription guidelines and recommendations (i.e., that an-
xiolytics are appropriate only for short-term treatment of
anxiety disorders and introduction of psychopharmacolo-
gical treatment in depression), but they have difficulties
in refusing the prescription of anxiolytics, especially if
the patient had positive experiences with these drugs24.
Different methods like education, feedback of quality-
-of-use review, and physician prescribing reminders are
available to facilitate a change to more rational prescrib-
ing of benzodiazepines in elderly patients in primary
care. In addition, further research is needed to investi-
gate the prescribers’ attitudes and actual prescribing,
and examine how to change attitudes and behaviour to
improve performance. Doctors need to be aware of and
discuss these beliefs in the context of available evidence
to make informed and collaborative decisions about their
diagnostic and prescribing practices among older patient
population, which usually require more time for diagno-
sis and treatment decisions34.
The study showed that the total amount of prescribed
antidepressant drugs notably increased during the ob-
served time-period. The changes in antidepressant pre-
scribing volumes are plausible because more elderly pa-
tients are on long-term medication and this group con-
sumes the most drugs. Nevertheless, in order to better
understand the rise in antidepressant prescribing, future
research needs to focus on encouraging high-quality mo-
nitoring and regular review of medication35. On a more
general note, more clarity would be welcome over the ef-
fectiveness and appropriateness of using psychotropic
drugs in the various illness, symptom and life-stress pre-
sentations seen in primary care.
Despite the obvious lack of detail on the patients’
health status, evaluating a large database has its advan-
tages. On a related note, there are other measures of
good or appropriate prescribing, such as evaluating the
duration of drug use, or the use of lower dosages in older
people, but such questions could only have been an-
swered through chart audits or direct patient surveys.
Future studies could identify whether particular regions
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or specific family physicians exhibit particularly poor
prescribing habits, which could in turn lead to targeted
education programs if further improvement is consid-
ered necessary beyond the current trends. We believe
that the obtained data may be important for the im-
provement of health care and serve for evidence-based
comparison of anxiolytic and antidepressant drug utilisa-
tion tendencies in other countries.
Conclusions
Benzodiazepines showed highest share in the overall
utilization of anxiolytics and antidepressants. The de-
crease in anxiolytic/antidepressant ratio from 2005 to
2008 was the smallest in the elderly population. The ra-
tio between short- and long-acting benzodiazepines de-
creased by about one tenth during the observed period.
Long-acting benzodiazepines were prescribed more often
to the older patients, however their use decreased in the
observed period. Further research is needed to ascertain
the prescribers’ attitudes in order to devise strategies to
further improve prescribing performance in elderly pa-
tients.
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VREMENSKI TRENDOVI NAVIKA PROPISIVANJA ANKSIOLITIKA I ANTIDEPRESIVA U
SLOVENSKIM ORDINACIJAMA OBITELJSKE MEDICINE (S NAGLASKOM NA STARIJIM
BOLESNICIMA)
S A @ E T A K
Cilj studije bio je istra`iti propisivanje anksiolitika i antidepresiva me|u slovenskim obiteljskim lije~nicima u po-
gledu vrste lijeka s naglaskom na starijoj populaciji i mogu}im vremenskim trendovima. Anketno istra`ivanje i analiza
na temelju registra provedeni su za recepte za antidepresive i anksiolitike izme|u sto obiteljskih lije~nika u Sloveniji u
2005. i 2008. godini. Lijekovi uklju~eni u studiju bili su klasificirani prema anatomsko-terapijsko-kemijskom sustavu
klasifikacije lijekova (ATC), a ATC podaci kori{teni su za izra~un definiranih dnevnih doza (DDD) na 1,000 stanovnika
prakse po danu. Identificirani su naj~e{}e propisani anksiolitici i antidepresivi i procijenjen je omjer anksiolitika i anti-
depresiva po dobnim skupinama pacijenata za obje prou~avane godine. Najve}i udio u ukupnom kori{tenju psihotrop-
nih lijekova pokazali su benzodiazepini. Omjer kratko- i dugodjeluju}ih benzodiazepina smanjio se za oko jednu dese-
tinu u promatranom razdoblju. Dugodjeluju}i benzodiazepini su propisani ~e{}e u starijih pacijenata. Smanjenje omjera
anksiolitika i antidepresiva od 2005. do 2008. godine bilo je najmanje u starijoj populaciji. Potrebna su daljnja istra`i-
vanja kako bi se utvrdili stavovi lije~nika i smislile strategije za dodatno pobolj{anje propisivanja u starijih bolesnika.
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